{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:28:24Z","timestamp":1786980504551,"version":"build-2736575974"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2018,3,2]],"date-time":"2018-03-02T00:00:00Z","timestamp":1519948800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Competitive State Research funding","award":["TYH2013345 and TYH2015313"],"award-info":[{"award-number":["TYH2013345 and TYH2015313"]}]},{"name":"Finnish Cancer Society","award":["(7553"],"award-info":[{"award-number":["(7553"]}]},{"name":"Finnish Urological Association","award":["2016 and 2017"],"award-info":[{"award-number":["2016 and 2017"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1007\/s10096-018-3217-7","type":"journal-article","created":{"date-parts":[[2018,3,2]],"date-time":"2018-03-02T05:33:34Z","timestamp":1519968814000},"page":"1055-1060","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Rectal E. coli above ciprofloxacin ECOFF associate with infectious complications following prostate biopsy"],"prefix":"10.1007","volume":"37","author":[{"given":"Inari","family":"Kalalahti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaisa","family":"Huotari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanerva","family":"Lahdensuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eveliina","family":"Tarkka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrikki","family":"Santti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antti","family":"Rannikko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anu","family":"P\u00e4t\u00e4ri-Sampo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,3,2]]},"reference":[{"key":"3217_CR1","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/j.eururo.2016.10.008","volume":"71","author":"GW Dy","year":"2017","unstructured":"Dy GW, Gore JL, Forouzanfar MH, Naghavi M, Fitzmaurice C (2017) Global burden of urologic cancers, 1990\u20132013. Eur Urol 71:437\u2013446","journal-title":"Eur Urol"},{"key":"3217_CR2","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1111\/j.1464-410X.2011.10677.x","volume":"109","author":"H Vasarainen","year":"2012","unstructured":"Vasarainen H, Lokman U, Ruutu M, Taari K, Rannikko A (2012) Prostate cancer active surveillance and health-related quality of life: results of the Finnish arm of the prospective trial. BJU Int 109:1614\u20131619","journal-title":"BJU Int"},{"key":"3217_CR3","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1056\/NEJMoa1606220","volume":"375","author":"FC Hamdy","year":"2016","unstructured":"Hamdy FC, Donovan JL, Lane JA, Mason M, Metcalfe C, Holding P et al (2016) The ProtecT trial: 10-year outcomes after monitoring, surgery, or radiotherapy for localized prostate cancer. N Engl J Med 375:1415\u20131424","journal-title":"N Engl J Med"},{"key":"3217_CR4","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1016\/j.juro.2013.08.088","volume":"191","author":"B Ehdaie","year":"2014","unstructured":"Ehdaie B, Vertosick E, Spaliviero M, Giallo-Uvino A, Taur Y, O'Sullivan M et al (2014) The impact of repeat biopsies on infectious complications in men with prostate cancer on active surveillance. J Urol 191:660\u2013664","journal-title":"J Urol"},{"key":"3217_CR5","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1016\/j.eururo.2006.05.003","volume":"50","author":"S Lindstedt","year":"2006","unstructured":"Lindstedt S, Lindstr\u00f6m U, Ljunggren E, Wullt B, Grabe M (2006) Single-dose antibiotic prophylaxis in core prostate biopsy: impact of timing and identification of risk factors. Eur Urol 50:832\u2013837","journal-title":"Eur Urol"},{"key":"3217_CR6","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/j.eururo.2012.06.003","volume":"63","author":"F Wegenlehner","year":"2013","unstructured":"Wegenlehner F, van Oostrum E, Tenke P, Tandogdu Z, Cek M et al (2013) Infective complications after prostate biopsy: outcome of the Global Prevalence Study of Infections in Urology (GPIU) 2010 and 2011, a prospective multinational multicentre prostate biopsy study. Eur Urol 63:521\u2013527. \n                    https:\/\/doi.org\/10.1016\/j.eururo.2012.06.003","journal-title":"Eur Urol"},{"key":"3217_CR7","doi-asserted-by":"publisher","first-page":"S12","DOI":"10.1016\/j.juro.2012.11.015","volume":"189","author":"RK Nam","year":"2013","unstructured":"Nam RK, Saskin R, Lee Y, Liu Y, Law C, Klotz LH et al (2013) Increasing hospital admission rates for urological complications after transrectal ultrasound guided prostate biopsy. J Urol 189:S12\u2013S18","journal-title":"J Urol"},{"key":"3217_CR8","unstructured":"Annual Report of the European Antimicrobial Resistance Surveillance Network (EARS-Net). \n                    https:\/\/ecdc.europa.eu\n                    \n                  \/ Accessed 22 Nov 2017"},{"key":"3217_CR9","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1038\/nrurol.2013.322","volume":"11","author":"FM Wagenlehner","year":"2014","unstructured":"Wagenlehner FM, Pilatz A, Waliszewski P, Weidner W, Johansen TE (2014) Reducing infection rates after prostate biopsy. Nat Rev Urol 11:80\u201386","journal-title":"Nat Rev Urol"},{"key":"3217_CR10","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1038\/nrurol.2015.199","volume":"12","author":"HM Zowawi","year":"2015","unstructured":"Zowawi HM, Harris PN, Roberts MJ, Tambyah PA, Schembri MA, Pezzani MD et al (2015) The emerging threat of multidrug-resistant Gram-negative bacteria in urology. Nat Rev Urol 12:570\u2013584","journal-title":"Nat Rev Urol"},{"key":"3217_CR11","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1093\/cid\/ciu1129","volume":"60","author":"MA Liss","year":"2015","unstructured":"Liss MA, Johnson JR, Porter SB, Johnston B, Clabots C, Gillis K et al (2015) Clinical and microbiological determinants of infection after transrectal prostate biopsy. Clin Infect Dis 60:979\u2013987","journal-title":"Clin Infect Dis"},{"issue":"8","key":"3217_CR12","doi-asserted-by":"publisher","first-page":"e2016036","DOI":"10.4084\/mjhid.2016.036","volume":"1","author":"W Ricciardi","year":"2016","unstructured":"Ricciardi W, Giubbini G, Laurenti P (2016) Surveillance and control of antibiotic resistance in the Mediterranean region. Mediterr J Hematol Infect Dis 1(8):e2016036. \n                    https:\/\/doi.org\/10.4084\/MJHID.2016.036","journal-title":"Mediterr J Hematol Infect Dis"},{"key":"3217_CR13","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.juro.2015.03.110","volume":"194","author":"MA Liss","year":"2015","unstructured":"Liss MA, Kim W, Moskowitz D, Szabo RJ (2015) Comparative effectiveness of targeted vs empirical antibiotic prophylaxis to prevent sepsis from transrectal prostate biopsy: a retrospective analysis. J Urol 194:397\u2013402","journal-title":"J Urol"},{"key":"3217_CR14","doi-asserted-by":"publisher","first-page":"7273","DOI":"10.1128\/AAC.01457-15","volume":"59","author":"K Marino","year":"2015","unstructured":"Marino K, Parlee A, Orlando R, Lerner L, Strymish J, Gupta K (2015) Comparative effectiveness of single versus combination antibiotic prophylaxis for TRUS-biopsy. Antimicrob Agents Chemother 59:7273\u20137275","journal-title":"Antimicrob Agents Chemother"},{"key":"3217_CR15","doi-asserted-by":"publisher","first-page":"301","DOI":"10.5489\/cuaj.1751","volume":"8","author":"JK Rudzinski","year":"2014","unstructured":"Rudzinski JK, Kawakami J (2014) Incidence of infectious complications following transrectal ultrasound-guided prostate biopsy in Calgary, Alberta, Canada: a retrospective population-based analysis. Can Urol Assoc J 8:301\u2013305","journal-title":"Can Urol Assoc J"},{"key":"3217_CR16","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/pcan.2016.36","volume":"19","author":"K Lahdensuo","year":"2016","unstructured":"Lahdensuo K, Rannikko A, Anttila VJ, Erickson A, P\u00e4t\u00e4ri-Sampo A, Rautio M (2016) Increase of prostate biopsy-related bacteremic complications in southern Finland, 2005\u20132013: a population-based analysis. Prostate Cancer Prostatic Dis 19:417\u2013422","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"3217_CR17","first-page":"37","volume":"24","author":"JJ Farrell","year":"2017","unstructured":"Farrell JJ, Hicks JL, Wallace SE, Seftel AD (2017) Impact of preoperative screening for rectal colonization with fluoroquinolone-resistant enteric bacteria on the incidence of sepsis following transrectal ultrasound guided prostate biopsy. Res Rep Urol 24:37\u201341","journal-title":"Res Rep Urol"},{"key":"3217_CR18","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.prnil.2016.06.001","volume":"4","author":"A Fahmy","year":"2016","unstructured":"Fahmy A, Rhashad H, Mohi M, Elabbadie A, Kotb A (2016) Optimizing prophylactic antibiotic regimen in patients admitted for transrectal ultrasound-guided prostate biopsies: a prospective randomized study. Prostate Int 4:113\u2013117","journal-title":"Prostate Int"},{"key":"3217_CR19","unstructured":"EUCAST Clinical breakpoints \n                    http:\/\/www.eucast.org\/clinical_breakpoints\/\n                    \n                   Accessed 22 Nov 2017"},{"key":"3217_CR20","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1128\/JCM.01885-10","volume":"49","author":"MA Liss","year":"2011","unstructured":"Liss MA, Peeples AN, Peterson EM (2011) Detection of fluoroquinolone-resistant organisms from rectal swabs by use of selective media prior to a transrectal prostate biopsy. J Clin Microbiol 49:1116\u20131118","journal-title":"J Clin Microbiol"},{"key":"3217_CR21","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1016\/j.juro.2011.11.115","volume":"187","author":"AK Taylor","year":"2012","unstructured":"Taylor AK, Zembower TR, Nadler RB, Scheetz MH, Cashy JP, Bowen D et al (2012) Targeted antimicrobial prophylaxis using rectal swab cultures in men undergoing transrectal ultrasound guided prostate biopsy is associated with reduced incidence of postoperative infectious complications and cost of care. J Urol 187:1275\u20131279","journal-title":"J Urol"},{"key":"3217_CR22","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1111\/j.1464-410X.2012.11637.x","volume":"111","author":"S Taylor","year":"2013","unstructured":"Taylor S, Margolick J, Abughosh Z, Goldenberg SL, Lange D, Bowie WR et al (2013) Ciprofloxacin resistance in the faecal carriage of patients undergoing transrectal ultrasound guided prostate biopsy. BJU Int 111:946\u2013953","journal-title":"BJU Int"},{"key":"3217_CR23","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1111\/j.1464-410X.2010.09294.x","volume":"106","author":"D Batura","year":"2010","unstructured":"Batura D, Rao GG, Nielsen PB (2010) Prevalence of antimicrobial resistance in intestinal flora of patients undergoing prostatic biopsy: implications for prophylaxis and treatment of infections after biopsy. BJU Int 106:1017\u20131020","journal-title":"BJU Int"},{"key":"3217_CR24","first-page":"2432","volume":"125","author":"ES Chan","year":"2012","unstructured":"Chan ES, Lo KL, Ng CF, Hou SM, Yip SK (2012) Randomized controlled trial of antibiotic prophylaxis regimens for transrectal ultrasound-guided prostate biopsy. Chin Med J 125:2432\u20132435","journal-title":"Chin Med J"},{"key":"3217_CR25","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1111\/bju.13402","volume":"117","author":"A Cussans","year":"2016","unstructured":"Cussans A, Somani BK, Basarab A, Dudderidge TJ et al (2016) The role of targeted prophylactic antimicrobial therapy before transrectal ultrasonography-guided prostate biopsy in reducing infection rates: a systematic review. BJU Int 117:725\u2013731","journal-title":"BJU Int"},{"key":"3217_CR26","doi-asserted-by":"publisher","first-page":"e0170319","DOI":"10.1371\/journal.pone.0170319","volume":"12","author":"L Boeri","year":"2017","unstructured":"Boeri L, Fontana M, Gallioli A, Zanetti SP, Catellani M, Longo F et al (2017) Rectal culture-guided targeted antimicrobial prophylaxis reduces the incidence of post-operative infectious complications in men at high risk for infections submitted to transrectal ultrasound prostate biopsy\u2014results of a cross-sectional study. PLoS One 12:e0170319","journal-title":"PLoS One"},{"key":"3217_CR27","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.juro.2017.01.103","volume":"198","author":"MA Liss","year":"2017","unstructured":"Liss MA, Ehdaie B, Loeb S, Meng MV, Raman JD, Spears V et al (2017) An update of the American Urological Association white paper on the prevention and treatment of the more common complications related to prostate biopsy. J Urol 198:329\u2013333","journal-title":"J Urol"},{"key":"3217_CR28","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1016\/j.urology.2014.04.060","volume":"84","author":"E Tukenmez Tigen","year":"2014","unstructured":"Tukenmez Tigen E, Tandogdu Z, Ergonul O, Altinkanat G, Gunaydin B, Ozgen M et al (2014) Outcomes of fecal carriage of extended-spectrum \u03b2-lactamase after transrectal ultrasound-guided biopsy of the prostate. Urology 84:1008\u20131015","journal-title":"Urology"}],"container-title":["European Journal of Clinical Microbiology &amp; Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10096-018-3217-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-018-3217-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-018-3217-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T20:32:39Z","timestamp":1551472359000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10096-018-3217-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,2]]},"references-count":28,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["3217"],"URL":"https:\/\/doi.org\/10.1007\/s10096-018-3217-7","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"value":"0934-9723","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,2]]},"assertion":[{"value":"4 December 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The ethics committee of the Department of Surgery at Helsinki University Hospital approved the study and the trial was registered at ClinicalTrial.Gov (\n                      \n                      ).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}